Compared to CGL1, CGL2 patients have lower leptin levels, an earlier onset of diabetes, mild cognitive impairment (which may be related to increased seipin expression in the brain [120]), higher insulin levels, and thus insulin resistance [130]. The gene discussed is INS; the disease is diabetes mellitus.